Literature DB >> 1328053

Functional characterization of neurokinin-1 receptors on human U373MG astrocytoma cells.

H R Eistetter1, A Mills, R Brewster, S Alouani, C Rambosson, E Kawashima.   

Abstract

The neurokinin-1 (NK-1, substance P) receptor belongs to the class of seven transmembrane domain (7-TM) receptors that interact with cellular effector systems via guanine nucleotide binding regulatory proteins (G-proteins). In this study, coupling mechanisms of functional NK-1 receptors endogenously expressed in a human astrocytoma cell line (U373MG) were analyzed. Stimulation with substance P (SP) resulted in 1) a rapid increase in inositol 1,4,5-trisphosphate (IP3) synthesis; 2) a rise in cytosolic free calcium concentration ([Ca2+]i); 3) induction of immediate early gene transcription as monitored by c-fos and c-jun expression; and 4) a significant increase in de novo DNA synthesis. Thus, the functional responses induced by stimulation of NK-1 receptors on U373MG strongly correlate with those observed after treatment of primary astrocytes with SP and make U373MG cells a useful in vitro model system for the analysis of NK-1 receptor function on astrocytes in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328053     DOI: 10.1002/glia.440060203

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  9 in total

Review 1.  G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues.

Authors:  A E Cherry; N Stella
Journal:  Neuroscience       Date:  2014-08-24       Impact factor: 3.590

Review 2.  Involvement of substance P and the NK-1 receptor in pancreatic cancer.

Authors:  Miguel Muñoz; Rafael Coveñas
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).

Authors:  Lingyun Mou; Yawei Kang; Ying Zhou; Qian Zeng; Hongjing Song; Rui Wang
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

Review 4.  The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.

Authors:  Miguel Munoz; Rafael Covenas; Francisco Esteban; Maximino Redondo
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

5.  Characteristics of the Ca(2+)-dependent inhibition of cyclic AMP accumulation by histamine and thapsigargin in human U373 MG astrocytoma cells.

Authors:  M P Wong; D M Cooper; K W Young; J M Young
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes.

Authors:  N Lambert; P L Lescoulié; B Yassine-Diab; G Enault; B Mazières; C De Préval; A Cantagrel
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

7.  Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.

Authors:  Michelle Z Dion; Danielle Leiske; Vikas K Sharma; Christina L Zuch de Zafra; Cleo M Salisbury
Journal:  Pharm Res       Date:  2018-10-02       Impact factor: 4.200

8.  Glioblastoma cells express functional cell membrane receptors activated by daily used medical drugs.

Authors:  Susanne A Kuhn; Ulrike Mueller; Uwe-K Hanisch; Christian R A Regenbrecht; Ilona Schoenwald; Michael Brodhun; Hartwig Kosmehl; Christian Ewald; Rolf Kalff; Rupert Reichart
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-19       Impact factor: 4.553

9.  Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.

Authors:  C Palma; F Nardelli; S Manzini; C A Maggi
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.